Skip to content

BCR (Breakpoint Cluster Region) Detection in Blood by Qualitative PCR

Published: August 9, 2026Updated: August 16, 2026

This test checks for the presence of a genetic abnormality involving the BCR and ABL genes, commonly linked to certain blood cancers like chronic myeloid leukemia (CML).

Quick summary

["Assesses for a genetic marker tied to specific blood disorders that may require targeted treatment."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
46434-7
Short code
t(9;22)(ABL1,BCR)/control Bld/T
Synonyms
t(9;22)(ABL1,BCR)/control Bld/T
Category
coagulation
Sample
whole-blood
Container
Lavender-top (EDTA)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
molgen
Specimen volume
3 mL
Stability
Room temperature: 4h, Refrigerated: 24h
Hemolysis max
0
Lipemia max
0
Icterus max
0
TAT
4–24 hours
Order
routine

Why This Test Is Done

Your doctor may order this test if you have symptoms of blood cancer, such as unexplained fatigue, weight loss, or swollen lymph nodes. It’s also used to monitor treatment progress in patients already diagnosed with certain blood disorders.

What to Expect Before the Test

No special preparation is needed. A small blood sample is drawn from a vein, usually in your arm. The process is quick and typically done in a clinic or lab setting.

How the Results Are Interpreted

Results are qualitative (yes/no) and indicate whether the BCR/ABL gene rearrangement is present. Positive results suggest the presence of the genetic abnormality linked to the condition being tested.

What the Results Mean

Positive results may confirm a diagnosis of certain blood cancers or monitor treatment effectiveness. Negative results mean the genetic marker is not detected in this sample.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

This test is critical for diagnosing chronic myeloid leukemia (CML) and guiding treatment decisions. It helps determine if the cancer is responding to therapy by detecting the BCR/ABL fusion gene, which drives the disease. Regular monitoring with this test ensures timely adjustments to treatment plans.

Short name

BCR/ABL Test (Qualitative PCR)

Frequently asked questions

What does a positive result mean?
A positive result indicates the presence of the BCR/ABL genetic rearrangement, which is strongly associated with chronic myeloid leukemia (CML) or other related blood disorders. This finding may lead to further evaluation or treatment planning.
Can this test be done on other body fluids?
This test is primarily performed on whole blood samples. However, if needed, other body fluids may be analyzed depending on clinical circumstances, but whole blood is the standard specimen for this test.
How often should I get this test?
The frequency of testing depends on your diagnosis and treatment plan. If you have CML or another BCR/ABL-related disorder, your doctor may recommend regular monitoring, often every few months or as directed by your treatment protocol.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy